These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 26417954

  • 1. Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women.
    Thomson KA, Baeten JM, Mugo NR, Bekker LG, Celum CL, Heffron R.
    Curr Opin HIV AIDS; 2016 Jan; 11(1):18-26. PubMed ID: 26417954
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa.
    Matthews LT, Jaggernath M, Kriel Y, Smith PM, Haberer JE, Baeten JM, Hendrix CW, Ware NC, Moodley P, Pillay M, Bennett K, Bassler J, Psaros C, Hurwitz KE, Bangsberg DR, Smit JA.
    AIDS; 2024 Jul 15; 38(9):1342-1354. PubMed ID: 38752557
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.
    Mugo NR, Ngure K, Kiragu M, Irungu E, Kilonzo N.
    Curr Opin HIV AIDS; 2016 Jan 15; 11(1):80-6. PubMed ID: 26575147
    [Abstract] [Full Text] [Related]

  • 7. The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.
    Murewanhema G, Malisheni M, Takah NF.
    Pan Afr Med J; 2021 Jan 15; 38():308. PubMed ID: 34178226
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Welcome to the preexposure prophylaxis revolution.
    Baeten J, McCormack S.
    Curr Opin HIV AIDS; 2016 Jan 15; 11(1):1-2. PubMed ID: 26633637
    [No Abstract] [Full Text] [Related]

  • 10. The European preexposure prophylaxis revolution.
    Cairns G, McCormack S, Molina JM.
    Curr Opin HIV AIDS; 2016 Jan 15; 11(1):74-9. PubMed ID: 26599164
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.
    Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P, Wilson CM, Gandhi M.
    Clin Infect Dis; 2018 Jan 06; 66(2):213-219. PubMed ID: 29020194
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions.
    Hodges-Mameletzis I, Fonner VA, Dalal S, Mugo N, Msimanga-Radebe B, Baggaley R.
    Drugs; 2019 Aug 06; 79(12):1263-1276. PubMed ID: 31309457
    [Abstract] [Full Text] [Related]

  • 17. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G, Tremblay C, Delaugerre C, Charreau I, Cua E, Rojas Castro D, Raffi F, Chas J, Huleux T, Spire B, Capitant C, Cotte L, Meyer L, Molina JM, ANRS IPERGAY study group.
    Lancet HIV; 2020 Feb 06; 7(2):e113-e120. PubMed ID: 31784343
    [Abstract] [Full Text] [Related]

  • 18. What people want from sex and preexposure prophylaxis.
    Grant RM, Koester KA.
    Curr Opin HIV AIDS; 2016 Jan 06; 11(1):3-9. PubMed ID: 26569183
    [Abstract] [Full Text] [Related]

  • 19. Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial.
    Gill K, Johnson L, Dietrich J, Myer L, Marcus R, Wallace M, Pidwell T, Mendel E, Fynn L, Jones K, Wiesner L, Slack C, Strode A, Spiegel H, Hosek S, Rooney J, Gray G, Bekker LG.
    Lancet Child Adolesc Health; 2020 Dec 06; 4(12):875-883. PubMed ID: 33222803
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States.
    Leech AA, Burgess JF, Sullivan M, Kuohung W, Horný M, Drainoni ML, Christiansen CL, Linas BP.
    AIDS; 2018 Nov 28; 32(18):2787-2798. PubMed ID: 30234602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.